Regal Entertainment Group (RGC) Competitors

Notice: This company has been marked as potentially delisted and may not be actively trading.

RGC vs. NAII, BGXX, FTLF, MDWD, CDXC, PTWO, CRVS, NVNO, VTVT, and CUE

Should you be buying Regal Entertainment Group stock or one of its competitors? The main competitors of Regal Entertainment Group include Natural Alternatives International (NAII), Bright Green (BGXX), FitLife Brands (FTLF), MediWound (MDWD), ChromaDex (CDXC), Pono Capital Two (PTWO), Corvus Pharmaceuticals (CRVS), enVVeno Medical (NVNO), vTv Therapeutics (VTVT), and Cue Biopharma (CUE). These companies are all part of the "medical" sector.

Regal Entertainment Group vs.

Natural Alternatives International (NASDAQ:NAII) and Regal Entertainment Group (NYSE:RGC) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, dividends, analyst recommendations, media sentiment, profitability, risk, institutional ownership, community ranking and valuation.

32.4% of Natural Alternatives International shares are owned by institutional investors. Comparatively, 0.1% of Regal Entertainment Group shares are owned by institutional investors. 20.6% of Natural Alternatives International shares are owned by company insiders. Comparatively, 2.0% of Regal Entertainment Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Regal Entertainment Group received 270 more outperform votes than Natural Alternatives International when rated by MarketBeat users. However, 73.23% of users gave Natural Alternatives International an outperform vote while only 56.22% of users gave Regal Entertainment Group an outperform vote.

CompanyUnderperformOutperform
Natural Alternatives InternationalOutperform Votes
227
73.23%
Underperform Votes
83
26.77%
Regal Entertainment GroupOutperform Votes
497
56.22%
Underperform Votes
387
43.78%

Natural Alternatives International has a beta of 0.58, indicating that its stock price is 42% less volatile than the S&P 500. Comparatively, Regal Entertainment Group has a beta of -0.34, indicating that its stock price is 134% less volatile than the S&P 500.

Natural Alternatives International has higher revenue and earnings than Regal Entertainment Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Natural Alternatives International$154.01M0.25$2.52M-$0.70-8.93
Regal Entertainment GroupN/AN/A-$5.87MN/AN/A

In the previous week, Natural Alternatives International had 2 more articles in the media than Regal Entertainment Group. MarketBeat recorded 2 mentions for Natural Alternatives International and 0 mentions for Regal Entertainment Group. Regal Entertainment Group's average media sentiment score of 0.50 beat Natural Alternatives International's score of 0.00 indicating that Natural Alternatives International is being referred to more favorably in the media.

Company Overall Sentiment
Natural Alternatives International Positive
Regal Entertainment Group Neutral

Regal Entertainment Group has a net margin of 0.00% compared to Regal Entertainment Group's net margin of -3.22%. Natural Alternatives International's return on equity of 0.00% beat Regal Entertainment Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Natural Alternatives International-3.22% -4.70% -2.77%
Regal Entertainment Group N/A N/A N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Natural Alternatives International
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Regal Entertainment Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Summary

Natural Alternatives International beats Regal Entertainment Group on 8 of the 12 factors compared between the two stocks.

Get Regal Entertainment Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for RGC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RGC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RGC vs. The Competition

MetricRegal Entertainment GroupMedicinals & botanicals IndustryMedical SectorNYSE Exchange
Market Cap$69.60M$1.29B$4.87B$17.60B
Dividend YieldN/A2.40%2.97%3.53%
P/E RatioN/A7.27239.1525.60
Price / SalesN/A9.472,355.2410.77
Price / CashN/A186.5446.9317.68
Price / Book5.822.044.764.87
Net Income-$5.87M-$169.86M$103.41M$964.96M

Regal Entertainment Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NAII
Natural Alternatives International
0 of 5 stars
$6.37
-2.0%
N/A-30.8%$38.79M$154.01M-9.10317Analyst Report
Short Interest ↓
High Trading Volume
BGXX
Bright Green
0 of 5 stars
$0.20
flat
N/A-84.6%$37.60MN/A-2.4723Positive News
FTLF
FitLife Brands
0 of 5 stars
$27.95
-0.3%
N/A+69.0%$128.57M$52.70M25.8827
MDWD
MediWound
1.451 of 5 stars
$16.41
+4.1%
$32.00
+95.0%
+61.7%$149.59M$18.69M-21.31100News Coverage
CDXC
ChromaDex
3.4878 of 5 stars
$3.40
+15.3%
$5.87
+72.5%
+160.6%$256.05M$83.57M-48.56106Short Interest ↑
PTWO
Pono Capital Two
0 of 5 stars
$14.37
+19.8%
N/A+32.0%$75.01MN/A0.00N/ANews Coverage
Gap Up
CRVS
Corvus Pharmaceuticals
1.4308 of 5 stars
$1.53
+6.3%
$6.63
+333.0%
+41.5%$75.03MN/A-2.6828Gap Up
NVNO
enVVeno Medical
0.1812 of 5 stars
$5.50
+12.0%
N/A+32.8%$73.26MN/A-2.8619
VTVT
vTv Therapeutics
0 of 5 stars
$24.33
-0.5%
N/A-9.3%$73.23M$2.02M-2.4216Positive News
Gap Up
CUE
Cue Biopharma
3.3717 of 5 stars
$1.50
-4.5%
$8.00
+433.3%
-65.9%$72.96M$5.49M-1.3653Short Interest ↑

Related Companies and Tools

This page (NYSE:RGC) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners